adUnits.push({
code: ‘Rpp_peru_actualidad_Nota_Interna1’,
mediaTypes: {
banner: {
sizes: (navigator.userAgent.match(/iPhone|android|iPod/i)) ? [[300, 250], [320, 460], [320, 480], [320, 50], [300, 100], [320, 100]] : [[300, 250], [320, 460], [320, 480], [320, 50], [300, 100], [320, 100], [635, 90]]
}
},
bids: [{
bidder: ‘appnexus’,
params: {
placementId: ‘14149971’
}
},{
bidder: ‘rubicon’,
params: {
accountId: ‘19264’,
siteId: ‘314342’,
zoneId: ‘1604128’
}
},{
bidder: ‘amx’,
params: {
tagId: ‘MTUybWVkaWEuY29t’
}
},{
bidder: ‘oftmedia’,
params: {
placementId: navigator.userAgent.match(/iPhone|android|iPod/i) ? ‘22617692’: ‘22617693’
}
}]
});
The Ministry of Health (Minsa) approved a technical health standard establishing a “safe, voluntary and free” vaccine to “protect the life and health of the population most affected” by the coronavirus. monkeypox.
Ministerial Decree No. 193-MINSA/DGIESP-2022, published yesterday in an extraordinary issue of the Official Gazette. Peruvian manthe health sector has set provisions for the implementation vaccination against illness.
Areas of use
The aforementioned “must comply” rule provides administrative instructions for health workers, vaccination-related organs and structural units of the Minsa, regional health departments and medical institutions “in programming, implementing, evaluating, overseeing and coordinating vaccination-related activities at the national level” .
In this sense, there are two types of preventive use: pre-exposure vaccination and post-exposure vaccination. The first includes people “in the AIDS stage” or “not on antiretroviral treatment” and “people with risky sexual behavior.”
For this latter group, the rule states that priority will be given to “men who have sex with other men, transgender women and sex workers.”
in vaccination preliminary exposure Also included will be “medical personnel directly working with monkeypox specimens”.
On the other hand, vaccination after exposure It will target people “who have had direct occupational or sexual contact”, “with a confirmed case of monkeypox and who are at high risk of complications”. In this regard, it is specified that it will be administered “up to 4 days after contact with a confirmed case.”
On the other hand, Minsa indicated that “the designation of the population of people living with HIV and key populations for vaccination” will be carried out “on the basis of the name register of the healthcare institution in which they are treated.”
The ministry also clarified that the provision of vaccines and syringes for compliance with the norm, as well as resources for current expenses, correspond “Regional Governments and DIRIS Metropolitan of Lima”.
Nearly 3,000 infections across Peru
On the other hand, until last Friday, October 13, Minsa reported that the number of monkeypox cases in Peru had risen to 2,820, up 35 infections from the previous report.
According to the agency, cases are spread across 19 regions, with the largest number of cases occurring in the capital of Lima (2189), while other affected areas are also found in the provinces of Lima (34), Callao (190), La Libertad (132). , Arequipa (116), Piura (26) and Lambayeque (24).
Ministry of Health care noted that there are cases of the disease in Ukayali (19), Ica (16), San Martin (14), Cusco (14), Loreto (11), Tacna (10), Ancash (6), Madre de Dios (6), Junin (5), Huanuco (3) ), Cajamarca (2) and Puno (1).
Prior to this report, 2,500 patients have been discharged and 320 are still under medical observation. Minsa through their social networks.
Source: RPP
I’m Liza Grey, an experienced news writer and author at the Buna Times. I specialize in writing about economic issues, with a focus on uncovering stories that have a positive impact on society. With over seven years of experience in the news industry, I am highly knowledgeable about current events and the ways in which they affect our daily lives.